Journal Information
Vol. 5. Issue 3.
Pages 103-108 (May - June 2009)
Share
Share
Download PDF
More article options
Vol. 5. Issue 3.
Pages 103-108 (May - June 2009)
Full text access
Measurement of health-related quality of life and functional capacity in patients with chronic tophaceous gout
Medición de la calidad de vida asociada a la salud y a la capacidad funcional en pacientes con gota crónica tofácea
Visits
4719
Everardo Álvarez-Hernández
Corresponding author
everalvh@yahoo.com.mx

Corresponding author.
, Jorge A. Zamudio-Lerma, Gabriela Burgos-Martínez, Sandra E. Álvarez-Etchegaray, Ingris Peláez-Ballestas, J. Vázquez-Mellado
Servicio de Reumatología, Hospital General de México, México D.F., Mexico
This item has received
Article information
Abstract
Introduction

In gout there are few instruments validated for the evaluation of activity, functional capacity, or quality of life. It is not known if generic instruments such as the MOS-20, or specific for other illnesses, such as the AIMS, can be applied to patients with gout.

Objective

To evaluate the clinimetric characteristic of the MOS-20 and AIMS questionnaires, and their correlation with HAQ-DI, as well as with clinical variables in patients with tophaceous gout (TG).

Methods

Fortyy-nine patients with TG were included. Demographic and clinical variables were obtained. The 3 questionnaires were applied at the basal evaluation. A second evaluation was applied to 20 patients, 8 weeks later.

Results

All patients were male. The time of since onset of the illness was 14.9 (8.3) years. The HAQ-DI was 0.43 (0.56) with an alpha of Cronbach (αC) of 0.95 and the intraclass correlation coefficient (ICC) was 0.86. The MOS-20 had an αC of 0.68 to 1.0 and a ICC of 0.27 to 0.61 between the several components. The AIMS had an αC of 0.66 to 0.96, and a ICC of 0.11 to 0.79 between the several components. Reliability was better between the physical components in MOS-20 and AIMS. The MOS-20, AIMS and the HAQ-DI correlated with the presence of joints with functional limitation. There weren’t any significant differences among the patients with inflamed joints, nor in those with tophi. The HAQ-DI was best correlated with the physical component than with the mental component of the AIMS and the MOS-20.

Conclusion

The AIMS, the MOS-20 and the HAQ-DI are useful in measuring the functional capacity and the quality of life in patients with TG.

Keywords:
Tophaceus gout
Health-related quality of life
Functional capacity
Resumen
Introducción

Hay pocos instrumentos en el estudio de gota validados para evaluar la actividad, la capacidad funcional o la calidad de vida de los pacientes. Se desconoce si los instrumentos genéricos como el cuestionario MOS-20 (Medical Outcomes Study Short Form Health Survey “Resultados médicos del formulario corto del estudio de la encuesta de salud”) o los instrumentos específicos para otras enfermedades, como el cuestionario AIMS (Arthritis Impact Measurement Scales “Escala de medición del impacto de la artritis”) puedan aplicarse a pacientes con gota.

Objetivo

Evaluar las características clinimétricas de los cuestionarios MOS-20 y AIMS y su correlación con el cuestionario HAQ-DI (Health Assessment Questionnaire ‘Cuestionario de evaluación de salud’) así como con variables clínicas en los pacientes con gota crónica tofácea (GCT).

Pacientes y métodos

Se incluyeron 49 pacientes con GCT. Se obtuvieron las variables demográficas y clínicas. Se aplicaron los 3 cuestionarios en la valoración basal. En 20 pacientes se realizó una segunda evaluación después de 8 semanas.

Palabras clave:
Gota crónica tofácea
Calidad de vida relacionada con la salud
Capacidad funcional
Full text is only aviable in PDF
References
[1.]
R.L. Wortmann, W.N. Kelley.
Gout and hiperuricemia.
Kelley's texbook of Rheumatology, pp. 1339-1376
[2.]
K.T. Rott, C.A. Agudelo.
Gout JAMA, 289 (2003), pp. 2857-2860
[3.]
K.O. Waselman, C.A. Agudelo.
Gout basics.
Bull Rheum Dis, 50 (2001), pp. 1-3
[4.]
H.H. Colwell, B.J. Hunt, B.J. Pasta, W.A. Palo, S.D. Mathias, N. Joseph-Ridge.
Gout Assessment Questionnaire: Initial results of reliability, validity and responsiveness.
Int J Clin Pract, 60 (2006), pp. 1210-1217
[5.]
J. Vazquez-Mellado, J. Cruz, S. Guzman, J. Casasola-Vargas, L. Lino, R. Burgos-Vargas.
Severe tophaceous gout. Characterization of low socioeconomic level patients from México.
Clin Exp Rheumatol, 24 (2006), pp. 233-238
[6.]
R.C. Geletka, M.S. Hershfield, E.L. Scarlett, J.S. Sundy.
Severe gout is associated with impaired quality of life and functional status (Abstract).
Arthritis Rheum, 50 (2004), pp. S340
[7.]
J. Alvarez-Nemegyei, J.C. Cen-Piste, M. Medina-Escobedo, S. Villanueva-Jorge.
Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.
J Rheumatol, 32 (2005), pp. 1923-1927
[8.]
E. Álvarez-Hernández, I. Peláez-Ballestas, J. Vázquez-Mellado, L. Terán-Estrada, A.G. Bernard-Medina, V.J. Espinoza, et al.
Validation of the Health Assessment Questionnaire-Disability index in patients with gout.
Arthritis Car Res, 59 (2008), pp. 665-669
[9.]
I. Pelaez-Ballestas, J. Vazquez-Mellado, L. Teran, A. Bernard, J. Espinoza, M. Garza, et al.
Clinical variables associated with health status in patients with gout (abstract).
Ann Rheum Dis, 65 (2006), pp. 436
[10.]
M. Abello-Banfi, M.H. Cardiel, R. Ruíz-Mercado, D. Alarcón-Segovia.
Quality of life in rheumatoid arthritis: Validation of a Spanish version of the Arthritis Impact Measurement Scales (Spanish-AIMS).
J Rheumatol, 21 (1994), pp. 1250-1255
[11.]
A. Stewart, R. Hays, J. Ware.
The MOS Short-form General Health Survey. Reliability and validity in a patient population.
Medical Care, 26 (1998), pp. 724-735
[12.]
M.Y. Smith, J. Feldman, P. Kelly, J.A. DeHovitz, K. Chirgwin, H. Minkoff.
Health-related quality of life of HIV-infected women: Evidence for the reability, validity and responsiveness of the Medical Outcomes Survey Short-Form 20.
Qual Life Res, 51 (1996), pp. 47-55
[13.]
J.F. Fries, P.W. Spitz, D.Y. Young.
The dimensions of health outcomes: The health assessment questionnaire, disability and pain scales.
J Rheumatol, 9 (1982), pp. 789-793
[14.]
B. Bruce, J.F. Fries.
The Stanford Health Assessment Questionnaire: Dimensions and practical applications.
Health Qual Life Outcomes, 9 (2003), pp. 1-20
[15.]
B. Bruce, J.F. Fries.
The Stanford Health Assessment Questionnaire: A review of its history, issues, progress, and documentation.
J Rheumatol, 30 (2003), pp. 167-178
[16.]
M.H. Cardiel, M. Abello-Banfi, R. Ruiz-Mercado, D. Alarcón-Segovia.
How to measure health status in rheumatoid arthritis in non-English speaking patients: Validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI).
Clin Exp Rheumatol, 11 (1993), pp. 117-121
[17.]
S.L. Wallace, H. Robinson, A.T. Masi, J.L. Decker, D.J. McCarty, T.F. Yu.
Preliminary criteria for the classification of the acute arthritis of primary gout.
Arthritis Rheum, 20 (1977), pp. 895-900
[18.]
O. Steinbrocker, C.H. Trager, R.C. Batterman.
Therapeutic measurement in rheumatoid arthritis.
JAMA, 140 (1949), pp. 659-662
[19.]
J.S. Spiegel, H.E. Paulus, N.B. Ward, T.M. Spiegel, B. Leake, R.L. Kane.
What are we measuring? An examination of walk time and grip strength.
J Rheumatol, 14 (1987), pp. 80-86
[20.]
M. Bronfman, H. Guiscafre, V. Castro, R. Castro, G. Gutierrez.
La medición de la desigualdad: una estrategia metodológica, análisis de las características socioeconómicas de la muestra.
Arch Invest Med (Mex), 19 (1988), pp. 351-360
Copyright © 2009. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?